BIT 23.4% 3.6¢ biotron limited

chart daily, page-2228

  1. 16,267 Posts.
    lightbulb Created with Sketch. 743
    The Pfizer news was released yesterday in the US .



    https://www.pfizer.com/news/press-release/press-release-detail/pfizer-announces-additional-phase-23-study-results?linkId=144245904



    • An approximate 10-fold decrease in viral load at Day 5, relative to placebo, was observed in both EPIC-HR and EPIC-SR, indicating robust activity against SARS-CoV-2 and representing the strongest viral load reduction reported to date for a COVID-19 oral antiviral agent
    • Recent in vitro data confirm that nirmatrelvir is a potent inhibitor of the Omicron 3CL protease, which, combined with existing in vitro antiviral and protease inhibition data from other Variants of Concern (VoC) including Delta, indicates that PAXLOVID will retain robust antiviral activity against current VoCs as well as other coronaviruses
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.6¢
Change
-0.011(23.4%)
Mkt cap ! $32.48M
Open High Low Value Volume
4.8¢ 4.8¢ 3.5¢ $444.5K 11.21M

Buyers (Bids)

No. Vol. Price($)
2 459179 3.6¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 71980 2
View Market Depth
Last trade - 16.10pm 26/06/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.